Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alvotech Value Rises Again As Portion Of Debt Is Wiped Away

Bondholders Convert Debt To Equity

Jun 30 2021

• By Dean Rudge

DollarsGraph — Alvotech issued a $300m convertible bond at the end of 2018 • Source: Shutterstock

Related Content

Alvotech To Develop Biosimilar Assets With US$300m Financing Deal

Jan 28 2019

Private Financing Round Values Alvotech At $1.5bn

Oct 28 2020

Alvotech Gears Up For Public Listing With Fresh Leadership

May 19 2020

Alvotech Adalimumab Biosimilar Switching Study Hits Key Date

Jun 16 2021

Alvotech Completes $100m Private Placement

Mar 15 2021

Partnerships Provide Global Foundation For Alvotech

Dec 15 2020

Alvotech And Fuji Pharma Broaden Biosimilar Alliance In Japan

Dec 10 2020

Related Companies

Alvotech

Additional Topics

Iceland Europe Financing Strategy Biosimilars BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window